ARX vs EMD

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

51MEDIUM

EMD

EMYRIAL FPO [EMD]

51MEDIUM

Score Breakdown

ARX EMD
Technical
41
47
Catalyst
53
52
Sentiment
50
50
Fundamental
78
69
Momentum
69
76
Risk Gate
47
45

Key Metrics

ARX Metric EMD
$201.1MMarket Cap$29.0M
58KAvg Volume (20d)945K
+0.1%Short InterestN/A
$0.80052-Week High$0.078
$0.35052-Week Low$0.021
-2.6%Daily Change+2.8%
$0.565Entry Price$0.037
-2.0%ROE-58.6%
-2.0%Profit Margin-198.5%

Active Signals

ARX Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Above-average volume (1.5x) on a red day — sellers in control
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (2.2x)
●Moderate revenue growth (+15%)
●CANSLIM I: Institutional ownership (30%)

EMD Signals

●RSI is looking oversold — historically a spot where stocks tend to bounce
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Took a hit — down 14.0% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (11 quarters)
●Moderate P/S ratio (12.7x)

Ask Scout AI to compare ARX and EMD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ARX Full Analysis → EMD Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).